3 March 2024 - Hugel becomes the first and only Korean company that have market approvals in all three major aesthetic markets – US, Europe and China.

Hugel announced that the company has received marketing approval from the US FDA on the 29th (local time) for 50 units and 100 units of its botulinum toxin Letybo.

Read Hugel press release